- Supported exchanges /
- TW /
- 1762.TW
Chunghwa Chemical Synthesis & Biotech Co Ltd (1762 TW) stock market data APIs
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
Chunghwa Chemical Synthesis & Biotech Co Ltd Financial Data Overview
42.45 | |
42.6 | |
- | |
42.6 | |
42.4 | |
40.7-63.1 | |
3 320 M | |
28.5333 | |
77 560 K | |
1 507 M | |
0.738 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Chunghwa Chemical Synthesis & Biotech Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 507 M
- EBITDA 279 M
- Earnings Per Share 1.5
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Chunghwa Chemical Synthesis & Biotech Co Ltd Earnings via APIs
- Latest Release 2024-11-05
- EPS/Forecast NaN
Get Chunghwa Chemical Synthesis & Biotech Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: